Evidence map›Paper›PMID 40177387›Full record

ArticleNanoscale advances2025

Evaluation of cylindrical micelles assembled from amphiphilic β-peptides as antigen delivery nanostructures.

Clément Martin, Mélanie Côté-Cyr, Phuong Trang Nguyen, Denis Archambault, Steve Bourgault

Abstract read
In one paragraph

Article in Nanoscale advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Clément MartinDepartment of Chemistry, Université du Québec à Montréal C.P.8888, Succursale Centre-Ville Montréal H3C 3P8 Canada bourgault.steve@uqam.ca.
Mélanie Côté-CyrDepartment of Chemistry, Université du Québec à Montréal C.P.8888, Succursale Centre-Ville Montréal H3C 3P8 Canada bourgault.steve@uqam.ca.
Phuong Trang NguyenDepartment of Chemistry, Université du Québec à Montréal C.P.8888, Succursale Centre-Ville Montréal H3C 3P8 Canada bourgault.steve@uqam.ca.
Denis ArchambaultThe Swine and Poultry Infectious Diseases Research Centre (CRIPA) Saint-Hyacinthe J2S 2M2 Canada.
Steve BourgaultDepartment of Chemistry, Université du Québec à Montréal C.P.8888, Succursale Centre-Ville Montréal H3C 3P8 Canada bourgault.steve@uqam.ca.ORCID https://orcid.org/0000-0002-5563-8787

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Supramolecular nanostructures assembled from synthetic peptides constitute promising scaffolds for the delivery of antigens for vaccine development. Amphiphilic peptides and self-assembling cross-β-peptides have been shown to promote cellular uptake of antigenic epitopes by antigen-presenting cells, to stimulate the innate immune system and to induce a robust antigen-specific humoral immune response. In this study, we evaluated the use of cylindrical micelles assembled from the amphiphilic β-peptide C16V3A3K3 as a vaccine nanoplatform, combining the properties of cross-β-sheet fibrils and micelles. The ectodomain of the matrix 2 protein (M2e) of the influenza A virus was conjugated with a tetra-Gly linker at the C-terminus of C16V3A3K3. The chimeric peptide assembled into biocompatible unbranched filaments that exposed the antigen on the surface, and these filaments were readily internalized by dendritic cells and activated the toll-like receptor 2/6. These cylindrical micelles induced a robust M2e-specific humoral immune response upon intramuscular immunization in mice without the need for co-administration with adjuvants. Although this strong humoral response did not translate into protection against a lethal infection with the H1N1 influenza virus, these cylindrical micelles assembled from amphiphilic β-peptides expand the repertoire of self-adjuvanted nanostructures to enhance antibody production against peptide epitopes.

Identifiers

PMID40177387
PMCPMC11960782

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.